Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. scores highest on Torque (51) and lowest on Price (28). Its PosiPenta is 37.85 out of 100, weaker than most similar companies.
On the Penta Grid this week, Cognition Therapeutics, Inc. is Grid #608 of 837 in the Healthcare sector in United States, and Grid #3,079 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Cognition Therapeutics, Inc. | 37.85 | 28 | 43 | 37 | 51 | 30 |
| electroCore, Inc. | 53.77 | 0 | 51 | 64 | 99 | 55 |
| Fortress Biotech, Inc. | 57.23 | 93 | 46 | 27 | 69 | 50 |
| Champions Oncology, Inc. | 44.85 | 4 | 83 | 40 | 35 | 62 |
| Tenax Therapeutics, Inc. | 37.13 | 46 | 31 | 8 | 65 | 34 |
| Spero Therapeutics, Inc. | 51.82 | 75 | 39 | 24 | 74 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.29 |
| P/B ratio | 2.10 |
EEarnings
| Trailing EPS | ₹-16.10 |
| Forward EPS | ₹-20.84 |
NNitro
| Price | 69.12 |
| 52-week high | 182.80 |
| 52-week low | 52.09 |
| Fall from 52-week high | 62.2% |
TTorque
| Return on equity (ROE) | -83.76% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 1.80 |
| Market cap | ₹657 Cr |
| Insider holding | 1.29% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Cognition Therapeutics, Inc.'s PosiPenta score?
Cognition Therapeutics, Inc.'s PosiPenta is 37.85 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Cognition Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Cognition Therapeutics, Inc. is Grid #608 of 837 in the Healthcare sector in United States, and Grid #3,079 of 4,000 in United States.
Which PosiPenta pillar is strongest for Cognition Therapeutics, Inc.?
Torque (durability), with a score of 51 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Cognition Therapeutics, Inc.?
Price (valuation), with a score of 28 out of 100: weaker than most similar companies.
Has Cognition Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.75 points, from 34.10 to 37.85.
PositoAI is for research and education only and is not investment advice.